Latest Headlines

Latest Headlines

Biotech startup bags $7M stake needed to in-license PhII Merck anti-depressant

A biotech with close ties to Johns Hopkins has snagged an added $6.8 million in backing, which will be used to in-license an antidepressant out of the Merck pipeline and prep it for a Phase II study.

Biotech vets back $22M A round for neuroscience startup

The former CEO of Alba Therapeutics, Blake Paterson, has put together a $22 million A round to launch his new biotech in Baltimore.